small molecule compounds tocriscreen plus (Tocris)
Tocris is a verified supplier 
Tocris manufactures this product 
90
Structured Review
Tocris
small molecule compounds tocriscreen plus
Small Molecule Compounds Tocriscreen Plus, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small+molecule+compounds+tocriscreen+plus/tocriscreen+2+0+library/pmc12046374-48-4-17
Average 90 stars, based on 1 article reviews
Small Molecule Compounds Tocriscreen Plus, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/small+molecule+compounds+tocriscreen+plus/tocriscreen+2+0+library/pmc12046374-48-4-17
Average 90 stars, based on 1 article reviews
small molecule compounds tocriscreen plus - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Transcriptomic profiling of autophagy and apoptosis pathways in liver cancer cells treated with a new tyrosine kinase inhibitor PD161570 Article Snippet: A total of 3,271 small molecule compounds were sourced from the Prestwick Chemical Library containing 1,200 compounds, Tocriscreen plus (cat. no. 5840; Tocris Bioscience) with 1,119 compounds and SelleckChem Bioactive Compound Library-I (cat. no. L1700; Selleck Chemicals) comprising 952 compounds. Article Title: Transcriptomic profiling of autophagy and apoptosis pathways in liver cancer cells treated with a new tyrosine kinase inhibitor PD161570. Article Snippet: liver cancer is the third most lethal and prevalent cancer in the Asia‐Pacific regions.. Despite the use of tyrosine kinase inhibitors as first‐ and second‐line therapies, the overall survival rate for advanced liver cancer remains dismal and has not improved over the past decade.. The present study, through high‐throughput screening, identified and demonstrated that PD161570, a new tyrosine kinase inhibitor, inhibited cell growth and proliferation in liver cancer cells. |